US4383034A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for the production of human follicle-stimulating hormone
Assignee: Hayashibara Seibutsu Kagaku Kenkyujo KK
•
Filing: 1981-08-07
•
Granted: 1983-05-10
•
Expires: 2001-08-07
Abstract
Abstract The present invention relates to a process for the production of human follicle-stimulating hormone (hFSH). More precisely, the invention relates to a process for the mass production of hFSH, comprising in vivo multiplication of human cells capable of producing hFSH, and exposure of the multiplied human cells to a follicle-stimulating hormone inducer. The hFSH production according to the invention is much higher than that attained by conventional processes using in vitro tissue culture; thus, hFSH can be used in a sufficient amount in the prevention and treatment of human diseases.
Inventors
- 👤 Kaname Sugimoto
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 19:05
CPC Classifications
C; C12; C12N; C12N15/00; C07; C07K; C07K14/00; C07K14/435; C07K14/575; C07K14/59; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
189 words
A process for producing human follicle-stimulating hormone (hFSH) which comprises: (1) implanting human cells capable of producing hFSH into a non-human warm-blooded animal; feeding the animal to cause the human cells therein to multiply; extracting and disaggregating the resultant multiplied human cells formed in the animal; culturing the human cells in a nutrient medium in the presence of a follicle-stimulating hormone inducer for a period sufficient to accumulate a significant amount of hFSH; and harvesting the accumulated hFSH from the culture, or alternatively, (2) placing human cells capable of producing hFSH in suspension in a diffusion chamber; embedding the chamber in or placing the chamber, on a non-human warm-blooded animal in a manner such that the nutrient body fluid of the non-human warm-blooded animal is supplied to the cells within the chamber; feeding the animal to cause the human cells in the chamber to multiply; collecting the multiplied human cells from the chamber; culturing the human cells in a nutrient medium in the presence of a follicle stimulating hormone inducer for a period sufficient to accumulate a significant amount of hFSH; and harvesting the accumulated hFSH from the culture.
Claim 2
Dependent Claim
189 words
A process for producing human follicle-stimulating hormone (hFSH) which comprises: (1) implanting human cells capable of producing hFSH into a non-human warm-blooded animal; feeding the animal to cause the human cells therein to multiply; extracting and disaggregating the resultant multiplied human cells formed in the animal; culturing the human cells in a nutrient medium in the presence of a follicle-stimulating hormone inducer for a period sufficient to accumulate a significant amount of hFSH; and harvesting the accumulated hFSH from the culture, or alternatively, (2) placing human cells capable of producing hFSH in suspension in a diffusion chamber; embedding the chamber in or placing the chamber, on a non-human warm-blooded animal in a manner such that the nutrient body fluid of the non-human warm-blooded animal is supplied to the cells within the chamber; feeding the animal to cause the human cells in the chamber to multiply; collecting the multiplied human cells from the chamber; culturing the human cells in a nutrient medium in the presence of a follicle stimulating hormone inducer for a period sufficient to accumulate a significant amount of hFSH; and harvesting the accumulated hFSH from the culture.
Claim 3
Dependent Claim
39 words
A process as set forth in claim 1, wherein said human cells capable of producing hFSH are hybridoma cells derived by means of cell fusion of an established human lymphoblastoid line with human cells capable of inherently producing hFSH.
Claim 4
Dependent Claim
31 words
A process as set forth in claim 2, wherein said human cells capable of inherently producing hFSH which are fused to the established human lymphoblastoid line are human basophile adenoma cells.
Claim 5
Dependent Claim
20 words
A process as set forth in claim 2, wherein said established human lymphoblastoid line is a human leukemic lymphoblastoid line.
Claim 6
Dependent Claim
22 words
A process as set forth in claim 2, wherein said hybridoma cells are derived by means of cell fusion using Sendai virus.
Claim 7
Dependent Claim
18 words
A process as set forth in claim 4, wherein said human leukemic lymphoblastoid line is Namalwa or JBL.
Claim 8
Dependent Claim
30 words
A process as set forth in claim 1, wherein said follicle-stimulating hormone inducer is one or more members selected from the group consisting of amino acids, inorganic salts, and hormone.
Claim 9
Dependent Claim
19 words
A process as set forth in claim 1, wherein said non-human warm-blooded animal is a poultry or a mammalian.
Claim 10
Dependent Claim
43 words
A process as set forth in claim 8, wherein said follicle-stimulating hormone inducer is one or more members selected from the group consisting of lysine, arginine, tryptophan, leucine, casamino acid, sodium chloride, potassium chloride, calcium chloride, magnesium sulfate, and luteinizing hormone releasing hormone.
Claim 11
Dependent Claim
33 words
A process as set forth in claim 1, wherein said non-human warm-blooded animal is a chicken, pigeon, dog, cat, monkey goat, pig, cow, horse, rabbit, guinea pig, rat, hamster, mouse or nude mouse.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1986-05-09 | 1986-11-08 | 1987-05-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1990-05-09 | 1990-11-08 | 1991-05-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1994-05-09 | 1994-11-08 | 1995-05-10 | $7700.00 | Window Closed / Lapsed |